Rating History for Rapport Therapeutics (RAPP) by Truist Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/18/2026 | Danielle Brill | New Coverage | Buy (N/A) |
56.00 (N/A) |
37.07 (42.62) |
14.97% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/18/2026 | Danielle Brill | New Coverage | Buy (N/A) |
56.00 (N/A) |
37.07 (42.62) |
14.97% | Details |
![]() |
|||||||
![]() |
|||||||